312 Participants Needed

ECHO Model for Advanced Cancer Care Quality

Sriram Yennu | MD Anderson Cancer Center
Overseen BySriram Yennu
Age: Any Age
Sex: Any
Trial Phase: Academic
Sponsor: M.D. Anderson Cancer Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

Trial Summary

What is the purpose of this trial?

This trial investigates the experience and satisfaction of care in patients with cancer that has spread to other places in the body (advanced) and their caregivers living in underserved areas of Kenya, Nigeria, Ghana, South Africa, India and Ethiopia as part of Project Extension for Community Healthcare Outcomes (ECHO). Project ECHO is a model of medical education and care management that empowers clinicians to provide better care to more people where they live. Understanding the experiences and satisfaction of patients and caregivers may help improve healthcare workforce capacity and increase access to specialty care for the world's rural and underserved populations.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the research team or your doctor.

What data supports the effectiveness of the treatment Project ECHO for advanced cancer care?

The ECHO model has shown promise in building cancer control capacity among healthcare professionals, suggesting it could improve care quality for advanced cancer patients by enhancing knowledge and skills in underserved areas.12345

How does the ECHO Model for Advanced Cancer Care Quality differ from other treatments for advanced cancer?

The ECHO Model is unique because it uses a telementoring approach to improve cancer care by connecting local healthcare providers with specialists, allowing for shared knowledge and best practices without the need for patients to travel. This model helps reduce disparities in cancer care, especially in underserved areas, by providing high-quality education and support to healthcare professionals.46789

Research Team

Sriram Yennu | MD Anderson Cancer Center

Sriram Yennu

Principal Investigator

M.D. Anderson Cancer Center

Eligibility Criteria

This trial is for adult patients with advanced cancer and their caregivers in Kenya, Nigeria, Ghana, South Africa, India, and Ethiopia. Participants must be able to read English and have a life expectancy of at least one year. Caregivers need to be the primary support person. Healthcare providers interested in Project ECHO can also join if they commit for two years.

Inclusion Criteria

I am willing to stay in touch with the research team by phone or in person.
I am 18 years old or older.
Caregiver willing to be accessible to the research team for follow-up by telephone or in person
See 8 more

Exclusion Criteria

I am able to understand and sign the consent form.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

ECHO Clinics and Workshops

Participants participate in online ECHO clinics over 1 hour twice monthly for 12 months and in-country workshops twice per year.

12 months
24 online sessions, 2 in-country workshops

Patient and Caregiver Assessment

Patients and caregivers complete questionnaires and interviews about their experience and satisfaction with care.

24 months
3 in-person or phone questionnaires every 3 months for patients; up to 8 questionnaires for caregivers

Follow-up

Participants are monitored for changes in quality of life and symptom distress.

12 months

Treatment Details

Interventions

  • Project ECHO
Trial OverviewThe trial evaluates Project ECHO's impact on palliative care quality through telementoring clinics, workshops, education programs for oncologists, medical chart reviews, and questionnaires assessing patient/caregiver satisfaction in underserved areas.
Participant Groups
3Treatment groups
Experimental Treatment
Group I: Arm III: Caregivers (questionnaire)Experimental Treatment1 Intervention
Caregivers complete an in-person or phone questionnaire over 5 minutes up to 8 times about their experience and satisfaction with the cancer care their family member has received. Caregivers complete a 15-minute interview in person or by phone their family member received by their physician.
Group II: Arm II: Patients (questionnaire, medical chart review)Experimental Treatment2 Interventions
Patients complete 3 in-person or phone questionnaires over a total of 20 minutes every 3 months for 2 years about their symptoms, emotional and physical well-being, and their experience and satisfaction with outpatient oncology care. Patients' medical charts are reviewed for data collection. Patients complete a 15 minute interview in person or phone about the care they received by their physician at baseline, end of month 4 and month 12.
Group III: Arm I: ECHO Participants (ECHO clinics, workshop, education)Experimental Treatment3 Interventions
Participants participate in online ECHO clinics over 1 hour twice monthly for 12 months and in-country workshops twice per year. Participants also receive 5 core lectures through an internet-based professional education curriculum.

Find a Clinic Near You

Who Is Running the Clinical Trial?

M.D. Anderson Cancer Center

Lead Sponsor

Trials
3,107
Recruited
1,813,000+

National Cancer Institute (NCI)

Collaborator

Trials
14,080
Recruited
41,180,000+

Findings from Research

There is a significant lack of research on the unique needs of cancer survivors with advanced or metastatic cancer, highlighting the necessity for better understanding their physical and psychosocial symptoms.
The National Cancer Institute has identified key research areas to address these gaps, including improving symptom management, enhancing communication between healthcare providers and patients, and developing tailored survivorship care models.
Survivorship for Individuals Living With Advanced and Metastatic Cancers: National Cancer Institute Meeting Report.Mollica, MA., Smith, AW., Tonorezos, E., et al.[2022]
A new conceptual framework has been developed to create quality indicators for end-of-life care in advanced cancer patients, focusing on improving pain management, symptom relief, and coordination of care.
The framework outlines five essential steps for developing these indicators, ensuring they are evidence-based, feasible, and relevant to the needs of seriously ill patients and their families.
A framework for assessing quality indicators for cancer care at the end of life.Seow, H., Snyder, CF., Mularski, RA., et al.[2009]
Only 5.0% of patients with advanced solid tumors received outpatient specialty palliative care (OSPC) in 2016, highlighting a significant gap in access to these services.
Patients were 19 times more likely to use OSPC if their oncologist's practice was located in the same facility as the OSPC clinic, and those living closer (under 30 minutes) were also significantly more likely to access these services, indicating that clinic location and travel time are critical factors in OSPC utilization.
System-Level Factors Associated With Use of Outpatient Specialty Palliative Care Among Patients With Advanced Cancer.Yu, JA., Ray, KN., Park, SY., et al.[2023]

References

Survivorship for Individuals Living With Advanced and Metastatic Cancers: National Cancer Institute Meeting Report. [2022]
A framework for assessing quality indicators for cancer care at the end of life. [2009]
System-Level Factors Associated With Use of Outpatient Specialty Palliative Care Among Patients With Advanced Cancer. [2023]
Building Cancer Control Capacity in Health Professionals Through Telementoring: A Survey Study of a Cancer Prevention and Survivorship Care ECHO Program. [2023]
Patient-Reported Outcome Measures to Improve the Care Continuum for Patients With Metastatic Breast Cancer: Opportunities and Implications for Nursing Practice. [2023]
Project ECHO Cancer Initiative: a Tool to Improve Care and Increase Capacity Along the Continuum of Cancer Care. [2021]
Implementation of a virtual multicenter gastrointestinal tumor board to reduce cancer disparities in Argentina. [2022]
Adapting and Developing an Academic and Community Practice Collaborative Care Model for Metastatic Breast Cancer Care (Project ADAPT): Protocol for an Implementation Science-Based Study. [2023]
Expanding Health Care Access Through Education: Dissemination and Implementation of the ECHO Model. [2022]